Raabe, F.J.; Slapakova, L.; Rossner, M.J.; Cantuti-Castelvetri, L.; Simons, M.; Falkai, P.G.; Schmitt, A.
Oligodendrocytes as A New Therapeutic Target in Schizophrenia: From Histopathological Findings to Neuron-Oligodendrocyte Interaction. Cells 2019, 8, 1496.
https://doi.org/10.3390/cells8121496
AMA Style
Raabe FJ, Slapakova L, Rossner MJ, Cantuti-Castelvetri L, Simons M, Falkai PG, Schmitt A.
Oligodendrocytes as A New Therapeutic Target in Schizophrenia: From Histopathological Findings to Neuron-Oligodendrocyte Interaction. Cells. 2019; 8(12):1496.
https://doi.org/10.3390/cells8121496
Chicago/Turabian Style
Raabe, Florian J., Lenka Slapakova, Moritz J. Rossner, Ludovico Cantuti-Castelvetri, Mikael Simons, Peter G. Falkai, and Andrea Schmitt.
2019. "Oligodendrocytes as A New Therapeutic Target in Schizophrenia: From Histopathological Findings to Neuron-Oligodendrocyte Interaction" Cells 8, no. 12: 1496.
https://doi.org/10.3390/cells8121496
APA Style
Raabe, F. J., Slapakova, L., Rossner, M. J., Cantuti-Castelvetri, L., Simons, M., Falkai, P. G., & Schmitt, A.
(2019). Oligodendrocytes as A New Therapeutic Target in Schizophrenia: From Histopathological Findings to Neuron-Oligodendrocyte Interaction. Cells, 8(12), 1496.
https://doi.org/10.3390/cells8121496